taylorr

View the first article on NMS myth busting View the second article on NMS myth busting The post NMS myth busting series (#3) appeared first on Community Pharmacy England.

View the first article on NMS myth busting The post NMS myth busting series (#2) appeared first on Community Pharmacy England.

    The post NMS myth busting series (#1) appeared first on Community Pharmacy England.

As we move into the warmer months, pharmacy teams may start to see people presenting with tick bites and potentially symptoms of Lyme disease. While tick bites/Lyme disease is not treatable under the Pharmacy First clinical pathway for infected insect bites, with patients needing to be signposted onwards, patients may present with a tick bite with an erythema [...]

The post Pharmacy First: Recognition of tick bites and the symptoms of Lyme disease appeared first on Community Pharmacy England.

The Lateral flow device tests supply service for patients potentially eligible for COVID-19 treatments (LFD service) will continue to be commissioned as an Advanced service through 2026/27. NHS England has agreed the fee for provision of the service will increase to £4.19 + VAT from 1st April 2026, following a request from Community Pharmacy England [...]

The post C-19 LFD service: commissioning continues through 2026/27 appeared first on Community Pharmacy England.